The health of an economy versus the health of its eaters.

The ICMR-INDIAB study and the Lancet 2023 update converge on the same uncomfortable picture: as Indian per-capita GDP doubles, diabetes prevalence outpaces it in absolute terms. Roughly 101 million diabetics, another 136 million pre-diabetic, 315 million hypertensive. The trajectory is not "developing world" anymore. It is a high-income disease profile arriving at a middle-income tax base.

The panel's point is not alarmism. It is sequencing. Most economies developed their healthcare infrastructure before their NCD bill arrived. India is paying the bill while still building the system that has to absorb it.

PM-KISAN at Rs 6,000 per year per landholder. MNREGA at roughly Rs 86,000 crore in the 2024-25 outlay. Karnataka's Gruha Lakshmi at Rs 2,000 a month to a woman head-of-household. Maharashtra's Ladki Bahin at Rs 1,500 a month. Tamil Nadu's Magalir Urimai Thogai at Rs 1,000. Treated separately, each looks like a scheme. Treated together, they are now a structural line in every state budget, somewhere between 0.6% and 1.5% of GSDP, every year, forever.

The reframe matters because the political economy has changed. Cash transfers used to be drought relief or election sweetener. They are now part of the floor a state guarantees its female adult population, irrespective of harvest or polling cycle. The infrastructure budget gets squeezed against this new line, not against the wage bill or the subsidy bill.

The Supreme Court was asked in 2022 (S. Subramaniam Balaji-era doctrine, revisited) to draw a line between welfare entitlement and electoral inducement. It declined to draw it sharply, referred the matter to a larger bench, and the question is still hanging. The panel's working position is that the court is being asked the wrong question. The right question is not "is this a freebie?" but "does this raise the threshold below which a household cannot fall?"

If the answer is yes, the transfer is a floor. Floors are fiscal architecture, not fiscal weather, and they should be evaluated on what they prevent rather than on what they cost. PM-KISAN keeps a small farmer from selling land in a bad monsoon. Gruha Lakshmi keeps a woman's bank account active and her name on the receipt. These are not handouts; they are minimums.

The cohort the panel keeps returning to: a household that crossed Rs 3-5 lakh of annual income in the last fifteen years, often through a non-agri job, often with a woman drawing direct-benefit transfer alongside. It is roughly 80-120 million people, depending on whose definition you take. It is not the legacy middle class. It is not the poor. It votes its receipts.

This voter is missed by the upper-middle-class press because they are not visible in metro op-ed pages, and missed by left-of-centre analysis because the schemes are read as paternalism rather than as upward-mobility infrastructure. The 2024 Maharashtra result, where Ladki Bahin disbursement preceded the vote, is the cleanest test case so far.

The household biscuit packet, the breakfast cereal, the savoury extruded snack, the sweetened dairy drink. The packaged-food market crossed roughly $70B and is growing at high single digits, faster in tier-2 and tier-3 towns than in metros. The story being told in the conversation is not that Indians are choosing packets over home cooking. It is that the packet is now the cheaper, easier, longer-shelf-life default.

Choice architecture is doing the work. The shop's front shelf, the school tuck box, the office canteen, the Zepto reorder: every surface defaults toward the UPF option. A mother who would never serve her own child a UPF breakfast in 2005 now serves one in 2025 because the alternative requires forty extra minutes she does not have. The compounding effect is generational.

India taxed tobacco hard, taxed alcohol harder (state-by-state, the single largest non-GST revenue line in most states), taxed sugar-sweetened beverages partially in the 28%+ GST bracket, and has so far not taxed ultra-processed food as a category at all. The order is not random. It tracks which industries had the least political defence at the time the levy was attempted.

Tobacco lost first because its lobby is small and the disease load is undeniable. Alcohol survives at high tax because states cannot afford to lose the revenue, not because public-health framing won. Packaged food remains untaxed-as-a-category because the FMCG lobby is large, urban-employing, and aligned with the consumption story the country is telling about itself. Sequence reveals what budget speeches conceal.

From the 2022 PIL on poll promises through the referral to a three-judge bench, the apex court has been asked repeatedly to distinguish welfare from electoral bribery. It has declined to set a bright-line test. The reasoning, broadly: welfare is a Directive Principle, the legislature commands the purse, and a court that defines "freebie" defines the limit of democratic redistribution itself.

The political consequence is that every state government now operates with an implicit licence. So long as the transfer can be framed as welfare under Article 38 or 39, no court will strike it down. The fiscal consequence is that state-level competition has driven the floor up. Karnataka set it, Telangana matched, Maharashtra topped, Tamil Nadu had it already. There is no upper bound the court will enforce.

FSSAI's draft regulation for front-of-pack labelling, which flags products high in fat, sugar and salt (HFSS) with a star rating or warning label, has been in consultation since 2022. CSE and NITI Aayog have lined up in favour. The FMCG lobby has lined up against any warning-style label, pushing instead for the milder Health Star Rating model used in Australia. The current draft sits closer to the lobby than to the public-health side.

The framing fight is the policy fight. A warning label says "this product has too much sugar." A star rating says "this product has three out of five stars, the rest are imagined." Same data, opposite signal. The CSE position, borrowed from the Chilean octagonal warning experience, is that the warning works precisely because it does not flatter the product.

Rs 2,000 a month to roughly 1.2 crore women heads-of-household. Annual cost in the range of Rs 28,000 crore, about 12% of Karnataka's own-revenue tax receipts. The state's bond spreads barely moved when it was announced. Female bank-account activity and household consumption indices moved measurably. The political return, a state government re-elected on the promise of keeping the scheme, was direct.

The case is interesting because Karnataka is a high-fiscal-capacity state with a sophisticated finance department, not a populist one-off. The fact that a state of this profile chose a structural cash floor over additional infrastructure capex tells you that the political-economy equilibrium has shifted. The floor is now considered a higher-return investment than the road.

Even if FSSAI passes the strongest possible HFSS warning label tomorrow, the cohort that has been raised on packaged biscuits since 2008 is now twenty years old. The metabolic damage is in. The behavioural default, packet over preparation, is set. Policy that arrives now will protect the next cohort, not this one. That is not a failure of policy; it is the structure of public health.

The same lag works in reverse on the upside. PM-KISAN, MNREGA, and the female DBT schemes will pay out their full electoral and metabolic dividends a decade after they were enacted. Policy planted in 2014 is voting in 2024. Policy planted in 2024 will not vote until the 2030s. Anyone judging schemes on the next election cycle is reading the wrong clock.

Five years ago a centrally sponsored scheme set the floor and states added top-ups. Today, states are setting the floor and the centre is reacting. Ladki Bahin in Maharashtra forced a wider conversation about female DBT at the Union level. Karnataka's five guarantees forced Telangana's six. The federal-fiscal model is inverting, bottom-up rather than top-down, which the 16th Finance Commission has to absorb whether it wants to or not.

The implication for Union-level finance is severe. With states pre-committing 1-1.5% of GSDP to direct transfers, their willingness to take on capex-financing through borrowing falls. The capex burden falls back on the Union, which then has to choose between fiscal deficit and infrastructure spend. The trilemma is real; the panel does not pretend it isn't.

The thin-fat phenotype, well-documented in South Asian populations since the late 1990s, means an Indian body at a "normal" BMI of 23 carries the same metabolic risk profile as a European body at BMI 28. The genetic predisposition is real; what is new is the environmental trigger meeting the predisposition at scale. Diabetes diagnosis at 39 is not an outlier in tier-1 India anymore; it is the median.

The inheritance pattern matters for policy because the standard global threshold for "overweight", designed for European bodies, under-identifies risk in Indian ones. An Indian-specific BMI cutoff (already in ICMR guidance for some years) would reclassify tens of millions of people overnight. That reclassification has insurance, screening, and pharmaceutical-procurement implications the panel keeps coming back to.

Anjana, Pradeepa, Mohan et al, published in The Lancet Diabetes & Endocrinology in June 2023, drew on the ICMR-INDIAB cohort across 31 states and union territories. The headline numbers (101.3 million diabetics, 136 million pre-diabetics, 315.5 million hypertensives, 254 million with general obesity) are not extrapolations. They are measurements. The earlier 77-million-diabetic figure that policymakers had been quoting was an undercount.

The political consequence is that India can no longer plan a 2030 healthcare system on 2015 numbers. The clinical consequence is that screening windows are too late: by the time someone walks into a tier-2 clinic, the average duration of undiagnosed hyperglycaemia is years. The procurement consequence is that the insulin and metformin import dependency becomes a national-security-grade supply question.

The shape is recognisable. Rising disposable income meets rising shelf-availability meets rising marketing spend, and a packet that did not exist in a kitchen in 1995 is the default in 2025. The US went through this curve between roughly 1975 and 1995; obesity prevalence tracked it with a fifteen-year lag. India's curve started later, is steeper, and is meeting a population genetically more vulnerable to its consequences.

The honest version of the comparison is uncomfortable. The US has spent thirty years and trillions of dollars trying to reverse the curve and has not. The SNAP-sugary-drink debate is still alive; soda taxes only stick where city politics allows. The implication is not that India is doomed to repeat. It is that the window to act before the curve fully steepens is narrower than the optimism inside the budget speech suggests.

The pre-election conventional wisdom held that 2024 would be decided on the macro story: $5T, infrastructure capex, Vishwakarma-of-the-world. The actual electoral signal, read in retrospect, was different. The states that disbursed female DBT before the vote (Maharashtra's Ladki Bahin transferred Rs 1,500 monthly from August 2024) saw measurable swings. The states without comparable schemes saw less anchored votes.

The reading the panel converges on is that the new-rich cohort, having climbed, is now voting to lock in the staircase. They are not voting against the ceiling; they are not opposed to a $5T economy. They are voting for the floor that made the climb possible, and against any political project that threatens to remove it. The 2029 cycle will be fought on whose floor is higher.